CG
LJPC

Cutler Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Cutler Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50,800
Closed -$87K – 5899
2017
Q4 		$87K Sell
50,800
-19,200
-27% -$627K ﹤0.01% 1475
2017
Q3 		$88K Buy
70,000
+50,000
+250% +$1.61M ﹤0.01% 1778
2017
Q2 		$41K Sell
20,000
-14,800
-43% -$424K ﹤0.01% 2713
2017
Q1 		$92K Buy
34,800
+25,200
+263% +$643K ﹤0.01% 1827
2016
Q4 		$23K Buy
+9,600
New +$184K ﹤0.01% 3357
2016
Q3 		– Sell
-23,200
Closed -$28K – 8120
2016
Q2 		$28K Buy
23,200
+15,000
+183% +$269K ﹤0.01% 3030
2016
Q1 		$2K Buy
+8,200
New +$146K ﹤0.01% 5853

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Cutler Group's LJPC Position: Q2 2020 in Review

Cutler Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2020, closing a stake of 100 shares.

Cutler Group first reported a position in LJPC in Q4 2015 and held it in 13 quarters. The position peaked at $506K in Q4 2017. 76 funds tracked by Wall St. Rank hold LJPC as of Q2 2020.

  • Cutler Group reported no remaining La Jolla Pharmaceutical Company position as of Q2 2020 after selling out during the quarter.
  • Cutler Group sold 100 La Jolla Pharmaceutical Company shares in Q2 2020.
  • Cutler Group first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 13 quarters.
  • Cutler Group's La Jolla Pharmaceutical Company position peaked at $506K in Q4 2017.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2020.

Based on Cutler Group's 13F filing for Q2 2020, filed 22 Jul 2020.